Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,699.38
(
1.01%
)
US TECH 100
23,897.20
(
-0.49%
)
Dow Jones
46,946.41
(
0.83%
)
Brent Oil
100.84
(
2.58%
)
Bitcoin
74,431.49
(
-0.55%
)
News Focus
News Focus
Post# of 30493
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 842
Posts 122790
Boards Moderated 10
Alias Born 09/05/2002

DewDiligence

Member Level

Re: DewDiligence post# 10178

Friday, 11/13/2015 4:15:49 PM

Friday, November 13, 2015 4:15:49 PM

Post# of 30493
Chinese drug companies have problems with “suspect” clinical data:

http://health.economictimes.indiatimes.com/news/pharma/china-rejects-11-drug-applications-over-inadequate-trial-data/49763450

China has signalled a tougher stance on drug quality in the country's sprawling pharmaceuticals industry by rejecting applications for 11 medicines with inadequate or suspect clinical data.

The China Food and Drug Administration (CFDA) said in statement posted on its website on Nov. 11 that the move affected eight Chinese companies making generic drugs for heart problems, schizophrenia, pain, infections and other diseases.

A positive for multinational drugmakers who sell products in China.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Trade Smarter with Thousands

Leverage decades of market experience shared openly.

Join Now